NASDAQ:EIDX Shareholder Notice: Investigation of Eidos Therapeutics, Inc. Concerning Possible Violations of Securities Laws
Eidos Therapeutics, Inc. is under investigation over potential securities laws violations in connection with certain financial statements.
View full press release